Role of Lipid Antigen-Specific T Cells in the Anti-mycobacterial Immune Response of BCG/SIV Infected Macaques
脂质抗原特异性 T 细胞在 BCG/SIV 感染的猕猴抗分枝杆菌免疫反应中的作用
基本信息
- 批准号:9767660
- 负责人:
- 金额:$ 21.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-21 至 2021-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdultAerosolsAnimal ModelAntigen-Presenting CellsAntigensAntitubercular AgentsAutologousBCG LiveBCG VaccineBiopsyBloodBronchoalveolar LavageCD8-Positive T-LymphocytesCaviaCell physiologyCellsCessation of lifeCharacteristicsClinicalDataDevelopmentEvaluationExhibitsExposure toGene Expression ProfileGenesGoalsHIVHIV InfectionsHIV/TBHealthHumanImmuneImmune responseImmunityImpairmentIn VitroIndividualInfectionInterferon Type IIInterventionKnowledgeLipidsLungMacacaMacaca mulattaMediatingModelingMucous MembraneMusMycobacterium InfectionsMycobacterium bovisMycobacterium tuberculosisPeptidesPhenotypePilot ProjectsPlayPopulationPredispositionProtein IsoformsPulmonary PathologyPulmonary TuberculosisRecombinant ProteinsRecombinantsRegimenResistanceRiskRoleSIVSystemT cell responseT-Cell ReceptorT-LymphocyteT-Lymphocyte SubsetsTNF geneTestingTherapeuticTuberculosisTuberculosis VaccinesVaccinationVaccinesadaptive immune responseadaptive immunityantigen-specific T cellsarmbaseco-infectioncytokinecytotoxiccytotoxicitydesignimmune functionimprovedin vivoinsightmonocytemycobacterialnonhuman primatenovelperipheral bloodpreventprospectiveprotective effectrectalresponsetooltuberculosis immunityvaccination strategy
项目摘要
PROJECT SUMMARY
An estimated one third of the world's population is latently infected with Mycobacterium tuberculosis (Mtb), and
HIV infection significantly increases the risk of developing TB, making HIV/TB co-infection a serious health
threat. Conventional peptide antigen-specific CD4+ and CD8+ T cell responses play important roles in adaptive
immunity to Mtb and are being targeted by various vaccination strategies. However, the in vivo role of lipid
antigen-specific CD1-restricted T cell responses in TB immunity remains largely unknown despite an indication
of anti-TB potential in small animal models. We have found that Mtb lipid antigen-specific T cell cytokine and
cytotoxic responses can be detected in uninfected macaques suggesting that these immune responses may
play important roles in early defense against Mtb. Furthermore, we observed significantly higher Mtb lipid-
specific responses in cynomolgus macaques in comparison to rhesus macaques. Utilizing the BCG model of
mycobacterial exposure in cynomolgus macaques that display more potent innate Mtb lipid antigen-specific
responses, we aim to define the role of CD1-restricted immune responses in TB immunity. Our previous data
also indicate a decline in peripheral blood Mtb lipid antigen-specific responses of SIV-infected macaques. Thus
we propose that SIV infection induces perturbations in the host CD1-restricted immune responses that
contribute to increased risk of TB in co-infection. The specific aims of this proposal are focused on the
understanding of the in vivo role of CD1-restricted immune responses in protection against TB and the impact
of SIV infection on their anti-mycobacterial effector functions. In the first aim, the phenotypic and functional
characteristics of systemic and mucosal mycobacterial lipid-specific T cells will be examined longitudinally in
BCG-inoculated macaques to determine anti-mycobacterial effector functions and relationship with adaptive
immune responses. The anti-mycobacterial effector functions will be investigated by evaluation of in vitro
cytokine responses to lipid antigen-stimulation, cytotoxicity towards autologous Mtb-infected monocytes, and
activation of CD1-expressing antigen presenting cells. In the second aim, in order to understand their role in
SIV-induced reactivation of TB, the study will determine the impact of SIV infection on these effector functions
in blood and lungs of BCG-vaccinated macaques. These studies are relevant because they focus on
understanding novel mechanisms of mycobacterial immunity in the nonhuman primate model of TB and HIV.
The results will provide valuable insights into the immune mechanisms of protection against TB, and how
lentiviral infection impairs these mechanisms, and will open new avenues to explore specific lipid-based modes
of intervention in TB.
项目摘要
估计全球三分之一的人口受到结核分枝杆菌(MTB)和
艾滋病毒感染显着增加了患结核病的风险
威胁。常规的肽抗原特异性CD4+和CD8+ T细胞反应在自适应中起重要作用
对MTB的免疫力,并由各种疫苗接种策略作为目标。但是,脂质的体内作用
尽管有指示
小动物模型中的抗TB潜力。我们发现MTB脂质抗原特异性T细胞因子和
可以在未感染的猕猴中检测到细胞毒性反应,这表明这些免疫反应可能
在对MTB的早期防御中发挥重要作用。此外,我们观察到MTB脂质明显更高
与恒河猕猴相比,膀胱猕猴中的特定反应。利用BCG模型
甲状腺猕猴中的分枝杆菌暴露,显示出更有效的先天MTB脂质抗原特异性
反应,我们旨在定义CD1限制免疫反应在结核病免疫中的作用。我们以前的数据
还表明外周血MTB脂质抗原特异性反应的下降。因此
我们建议SIV感染会引起宿主CD1限制的免疫反应的扰动
有助于增加联合感染的结核病风险。该提案的具体目的是
了解CD1限制免疫反应在保护TB中的体内作用和影响
SIV感染在其抗细菌效应子功能上。在第一个目标中,表型和功能
全身性和粘膜分枝杆菌脂质特异性T细胞的特征将在纵向上检查
BCG接种猕猴以确定抗细菌效应子功能以及与自适应的关系
免疫反应。抗细菌效应子功能将通过评估体外研究
细胞因子对脂质抗原刺激的反应,对自体MTB感染的单核细胞的细胞毒性和
表达CD1的抗原呈递细胞的激活。在第二个目标中,为了了解他们在
SIV诱导的TB重新激活,该研究将确定SIV感染对这些效应子功能的影响
在BCG接种猕猴的血液和肺中。这些研究很重要,因为它们专注于
了解TB和HIV的非人类灵长类动物模型中分枝杆菌免疫的新型机制。
结果将为防止结核病的免疫机制以及如何提供宝贵的见解,以及如何
慢病毒感染会损害这些机制,并将开放新的途径以探索特定的基于脂质的模式
干预结核病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Namita Rout其他文献
Namita Rout的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Namita Rout', 18)}}的其他基金
Development of Gamma delta CAR-T cells to target CNS HIV reservoir
开发针对 CNS HIV 储存库的 Gamma delta CAR-T 细胞
- 批准号:
10620021 - 财政年份:2023
- 资助金额:
$ 21.25万 - 项目类别:
Innate immune mechanisms of epithelial barrier disruption during treated HIV and SIV infections
HIV 和 SIV 感染治疗期间上皮屏障破坏的先天免疫机制
- 批准号:
10668086 - 财政年份:2022
- 资助金额:
$ 21.25万 - 项目类别:
Gamma Delta T cell and microbial modulation to target chronic SIV-associated inflammation
Gamma Delta T 细胞和微生物调节靶向慢性 SIV 相关炎症
- 批准号:
10548685 - 财政年份:2022
- 资助金额:
$ 21.25万 - 项目类别:
Gamma Delta T cell and microbial modulation to target chronic SIV-associated inflammation
Gamma Delta T 细胞和微生物调节靶向慢性 SIV 相关炎症
- 批准号:
10666598 - 财政年份:2022
- 资助金额:
$ 21.25万 - 项目类别:
Genetically Modified Gamma Delta T Cells to Target SIV Reservoirs
转基因 Gamma Delta T 细胞靶向 SIV 储库
- 批准号:
10065758 - 财政年份:2018
- 资助金额:
$ 21.25万 - 项目类别:
Genetically Modified Gamma Delta T Cells to Target SIV Reservoirs
转基因 Gamma Delta T 细胞靶向 SIV 储库
- 批准号:
10314034 - 财政年份:2018
- 资助金额:
$ 21.25万 - 项目类别:
Genetically Modified Gamma Delta T Cells to Target SIV Reservoirs
转基因 Gamma Delta T 细胞靶向 SIV 储库
- 批准号:
10077819 - 财政年份:2018
- 资助金额:
$ 21.25万 - 项目类别:
Role of Innate Immunity and Microbiome in the Inflammation of Aging and Long-Term Antiretroviral Therapy
先天免疫和微生物组在衰老炎症和长期抗逆转录病毒治疗中的作用
- 批准号:
10402502 - 财政年份:2012
- 资助金额:
$ 21.25万 - 项目类别:
相似国自然基金
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
- 批准号:82302311
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Switching Individuals in Treatment for Opioid Use Disorder Who Smoke Cigarettes to the SREC
将接受阿片类药物使用障碍治疗且吸烟的个体转至 SREC
- 批准号:
10661301 - 财政年份:2023
- 资助金额:
$ 21.25万 - 项目类别:
The impact of a neonicotinoid pesticide on neural functions underlying learning and memory
新烟碱类农药对学习和记忆神经功能的影响
- 批准号:
10646631 - 财政年份:2023
- 资助金额:
$ 21.25万 - 项目类别:
Hale: A Mobile-Connected Medical Vaporizer that Alleviates Nicotine Dependence
Hale:一款可减轻尼古丁依赖的移动连接医疗蒸发器
- 批准号:
10740808 - 财政年份:2023
- 资助金额:
$ 21.25万 - 项目类别:
Vaccinating at Mucosal Surfaces with Nanoparticle-conjugated Antigen and Adjuvant
使用纳米颗粒结合的抗原和佐剂在粘膜表面进行疫苗接种
- 批准号:
10587388 - 财政年份:2023
- 资助金额:
$ 21.25万 - 项目类别:
Project 1: Manipulating E-cigarette Nicotine to Promote Public Health
项目一:操控电子烟尼古丁促进公众健康
- 批准号:
10666067 - 财政年份:2023
- 资助金额:
$ 21.25万 - 项目类别: